Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility.
Yoshihiro NawaHiroki KimuraDaisuke MoriHidekazu KatoMiho ToyamaSho FurutaYanjie YuKanako IshizukaItaru KushimaBranko AleksicYuko AriokaMako MorikawaTakashi OkadaToshiya InadaKozo KaibuchiKyung Sue HongMasashi IkedaMichio SuzukiYuko OkahisaJun EgawaToshiyuki SomeyaFumichika NishimuraTsukasa SasakiNorio OzakiPublished in: Human genome variation (2020)
Disabled 1 (DAB1) is an intracellular adaptor protein in the Reelin signaling pathway and plays an essential role in correct neuronal migration and layer formation in the developing brain. DAB1 has been repeatedly reported to be associated with neurodevelopmental disorders including schizophrenia (SCZ) and autism spectrum disorders (ASD) in genetic, animal, and postmortem studies. Recently, increasing attention has been given to rare single-nucleotide variants (SNVs) found by deep sequencing of candidate genes. In this study, we performed exon-targeted resequencing of DAB1 in 370 SCZ and 192 ASD patients using next-generation sequencing technology to identify rare SNVs with a minor allele frequency <1%. We detected two rare missense mutations (G382C, V129I) and then performed a genetic association study in a sample comprising 1763 SCZ, 380 ASD, and 2190 healthy control subjects. Although no statistically significant association with the detected mutations was observed for either SCZ or ASD, G382C was found only in the case group, and in silico analyses and in vitro functional assays suggested that G382C alters the function of the DAB1 protein. The rare variants of DAB1 found in the present study should be studied further to elucidate their potential functional relevance to the pathophysiology of SCZ and ASD.
Keyphrases
- autism spectrum disorder
- intellectual disability
- attention deficit hyperactivity disorder
- copy number
- signaling pathway
- bipolar disorder
- end stage renal disease
- genome wide
- chronic kidney disease
- risk assessment
- gene expression
- climate change
- drug delivery
- ejection fraction
- epithelial mesenchymal transition
- high throughput
- binding protein
- oxidative stress
- patient reported outcomes
- pi k akt
- molecular dynamics simulations
- cerebral ischemia